Acurx Pharmaceuticals, Inc.
ACXP
Revenue
0.00
0.000.00%
-Assets
6.58M
▼-2.53M▼-27.76%
3 Months ChangeLiabilities
3.15M
▲42.68k▲1.37%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 8-K
ID: 0001104659-24-087545
2024-08-08
Form 10-Q
ID: 0001558370-24-011587
2024-06-17
Form 8-K
ID: 0001104659-24-072270
2024-05-15
Form 8-K
ID: 0001104659-24-061579
2024-05-14
Form 10-Q
ID: 0001558370-24-008130
2024-03-18
Form 8-K
ID: 0001104659-24-035556
2023-11-15
Form 8-K
ID: 0001104659-23-118749
2023-11-14
Form 8-K
ID: 0001104659-23-118064
2023-11-13
Form 10-Q
ID: 0001558370-23-018824
2023-11-03
Form 8-K
ID: 0001104659-23-114274